Keene

Researchers are conducting a three-arm randomized pilot trial to improve breast cancer screening decisions among women aged 39 to 49 in rural settings. The study aims to refine a clinical trial protocol with input from community partners, patients, and primary care providers (PCPs) to enhance engagement and acceptability. The trial evaluates the MyMammogram decision aid alone or combined with a provider communication intervention, compared to usual care, focusing on the feasibility and acceptability of these approaches. PCPs are randomized to one of three groups: usual care, MyMammogram decision aid, or decision aid plus clinician communication where the provider receives the patient's breast cancer risk and preferences before the visit. The trial enrolls 30 female participants over two phases, each with 15 participants, to identify barriers and facilitators to participation and adherence. Eligible patients must have an upcoming primary care visit within four weeks and no recent mammogram or breast cancer history. Participants complete surveys before the intervention, after using the decision aid, and after their clinic visit. Researchers collect mammography screening data from medical records and assess intervention acceptability within one day of completing it. Qualitative interviews with patients and providers help understand their experiences. The study measures recruitment, retention, randomization, adherence, and acceptability, with data summarized quantitatively to guide future trial design.